A
ANI Pharmaceuticals, Inc.
ANIP · NASDAQ · Healthcare · 1.7B
Price · close
$75.35
-2.55% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
19.3×
Price / net assetsP/B
2.8×
Enterprise value / EBITDAEV/EBITDA
7.5×
Free cash flow yieldFCF yield
10.0%
Return on equityROE
14.5%
Operating margin
9.2%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
4.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.